Medicare Part B premiums will increase by nearly 10% in 2026, consuming much of seniors' Social Security COLA and raising out-of-pocket costs amid regulatory efforts to control spending.
CMS finalized the 2026 Medicare Physician Fee Schedule with minor reforms and introduced an interactive dashboard tracking payment rates across Medicare payment systems starting January 2026.
Health insurance premiums in rural America could increase by over $1,300 monthly in 2026 if Biden-era ACA marketplace subsidies expire. This change would impact millions of rural residents, highlighting disparities and market risks ahead of budget negotiations.
Geisinger Health Plan earns 2026 Best Insurance Company for Medicare Advantage in Pennsylvania, recognized for high-quality coverage and member services based on CMS quality measures.
CMS proposes to revamp Medicare Advantage Star Ratings, affecting insurer compliance and operations. Legal appeals and health system updates also impact the US market.
Medicare 2026 premiums surge nearly 10%, with fewer Medicare Advantage plans as insurers scale back. Explore key Medicare cost drivers and market impacts.
CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.
The U.S. government passed H.R. 5371, ending the shutdown and extending Medicare telehealth flexibilities through January 2026, ensuring continued coverage and retroactive payments for telehealth claims.
CMS introduces the Ambulatory Specialty Model, a new mandatory payment model for specialists treating low back pain and heart failure, effective from 2027 to improve care quality and reduce costs.
CMS issues National Coverage Determination for FDA-approved renal denervation treatment under Coverage with Evidence Development for uncontrolled hypertension in Medicare patients.
